Kiniksa Pharmaceuticals
KNSA
KNSA
54 hedge funds and large institutions have $132M invested in Kiniksa Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
54
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.23M | |
| 2 | +$1.35M | |
| 3 | +$1.28M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.08M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$893K |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$8.59M | |
| 3 | -$866K | |
| 4 |
First Manhattan
New York
|
-$866K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$654K |